Global Fund Approves Emergency Funding for TB and HIV Services in Crisis-Affected Lebanon and Iraq

The Global Fund to Fight AIDS, Tuberculosis and Malaria has approved US$1.48 million in emergency funding to sustain essential TB and HIV services in Lebanon and Iraq. Intensifying conflict across the Middle East since early 2026 has severely disrupted healthcare access, caused massive displacement exceeding 15 million people, and damaged health infrastructure in both countries, heightening the risk of communicable diseases. The funding will support diagnostics, laboratory capacity, mobile clinics, and procurement of medicines.

Context

Lebanon and Iraq have faced escalating conflicts since early 2026, leading to significant disruptions in healthcare access and infrastructure. The Global Fund's intervention comes as these countries grapple with the consequences of violence and displacement. The funding is intended to address the urgent healthcare needs arising from this crisis.

Why it matters

The approval of emergency funding is crucial for maintaining essential healthcare services in Lebanon and Iraq, where conflict has severely impacted public health. With over 15 million people displaced, the risk of communicable diseases like TB and HIV has escalated. This funding aims to prevent a health crisis amid ongoing instability.

Implications

The funding is likely to improve access to TB and HIV services for vulnerable populations in Lebanon and Iraq. Health outcomes may improve for those affected by the crisis, but continued conflict poses a risk to sustained healthcare efforts. The situation may also affect international responses to health crises in conflict zones.

What to watch

In the near term, observers should monitor the implementation of the funding and its impact on healthcare services in both countries. Additionally, the effectiveness of mobile clinics and the procurement of necessary medicines will be key indicators of success. Ongoing conflict dynamics may also influence the stability of healthcare delivery.